Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Income (Loss) (Unaudited)

v3.22.2.2
Condensed Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue, net
Operating expenses:        
Research and development 556,868 375,511 1,063,243 843,075
General and administrative 2,230,801 435,376 3,061,710 883,953
Total operating expenses 2,787,669 810,887 4,124,953 1,726,028
Loss from operations (2,787,669) (810,887) (4,124,953) (1,726,028)
Other income (expense)        
Interest income (expense) (1,100,507) 240 (1,345,944) 692
FMV income (expense) adjustment for Contingent Stock and Warrants 4,365,930 4,078,930
Total Other Income (Expense) 3,265,423 240 2,732,986 692
Net income (loss) and comprehensive income (loss) $ 477,754 $ (810,647) $ (1,391,967) $ (1,725,336)
Net earnings (loss) per share, basic and diluted $ 0.06 $ (0.17) $ (0.20) $ (0.37)
Weighted average shares used to compute net earnings (loss) per share, basic and diluted 8,669,372 4,827,000 6,928,217 4,712,000